Sign in Subscribe
Drugs

Novel Gene Transfer Strategy Combines Promoter and Transgene Activities for Improved Tumor Cell Inhibition

Strategic Insights

— 1 min read

A novel gene transfer strategy has been developed that combines promoter and transgene activities to improve tumor cell inhibition. Researchers at the University of Sao Paulo, led by B.E. Strauss, have shown that this approach can lead to more robust expression of the transgene and more effective inhibition of tumor cell proliferation. The new strategy utilizes the transcriptional properties of p53 to drive its own expression as well as act as a tumor suppressor, and demonstrates a regulatory feedback loop. This approach has the potential to improve cancer treatment outcomes and reduce the risk of cancer recurrence.

Key Takeaways:

  • The novel gene transfer strategy combines promoter and transgene activities to improve tumor cell inhibition.
  • The pCL retroviral system was modified to include a p53-responsive sequence, creating the pCLPG system.
  • The pCLPG system can be driven by p53 encoded within the virus construct and expression is modulated depending on the p53 phenotype.
  • The pCLPG system expresses the transgene at a higher level and inhibits tumor cell proliferation more robustly than the original pCL system.
  • The pCLPG vectors represent a new gene transfer strategy that synergizes the promoter and transgene activities.
  • This approach has the potential to improve cancer treatment outcomes and reduce the risk of cancer recurrence.
  • The study was published in Cancer Gene Therapy in 2005.

Statistics:

  • 12(12):935-946 (issue and page numbers of the study publication)
  • 2005 (year of publication)
  • Sao Paulo, Brazil (location of the research institution)
  • 10th floor, Building 2, Av Dr. Eneas de Carvalho Aguiar 44 (address of the research laboratory)
  • Macmillan Building, 4 Crinan St., London N1 9XW (international address of the journal publisher)

Sources:

  • B.E. Strauss et al., "A novel gene transfer strategy that combines promoter and transgene activities for improved tumor cell inhibition," Cancer Gene Therapy, vol. 12, no. 12, pp. 935-946, 2005.
  • NewsRx.com, "Novel Gene Transfer Strategy Combines Promoter and Transgene Activities for Improved Tumor Cell Inhibition," Health & Medicine Week, 2006.
  • University of Sao Paulo, School of Medicine, Heart Institute, Laboratory of Genetics & Molecular Cardiology.
  • Nature Publishing Group, Macmillan Building, 4 Crinan St., London N1 9XW, England.

Read more